Physician profile
Daniel V Mock
NPI 1669920880
$8,107.33
in general payments reported to CMS, 2019-2025
16 companies · $723 in 2025
The $723 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,126 · 2022: $1,385 · 2023: $1,494 · 2024: $3,380 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,021 · Travel and Lodging: $1,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,020.64 |
| Travel and Lodging | $1,576.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $6,696.92 | 2021-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $502.55 | 2022-2025 | Mosaic, Mc3 Nautilus(Tm) Ecmo Oxygenator, Vitalflow Console |
| Abbott Laboratories | $237.05 | 2021 | |
| Angiodynamics, INC. | $123.57 | 2022 | |
| Biotissue Holdings INC. | $121.77 | 2021 | |
| Davol INC. | $108.32 | 2021 | |
| Ethicon US, LLC | $84.45 | 2025 | Vistaseal |
| Elutia, INC. | $42.26 | 2021 | |
| Edwards Lifesciences Corporation | $40.14 | 2025 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $28.57 | 2025 | |
| Livanova USA, INC. | $27.96 | 2021 | |
| Merz Pharmaceuticals, LLC | $23.00 | 2025 | Xeomin, Inbrija |
| Solventum Corporation | $22.96 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Merck Sharp & Dohme LLC | $17.71 | 2022 | |
| Kci USA, INC. | $17.60 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.